UBS MSCI USA UCITS ETF (USD) A-dis is a equity ETF from UBS tracking the MSCI USA index through physical replication. Domiciled in Ireland and launched in 2012, the fund manages about 1.3 bn € and charges a TER of 0.10% — 10 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
UBS MSCI USA UCITS ETF (USD) A-dis competes with 13 other products on the same index (MSCI USA): it ranks 9th by fund size and 8th by ongoing cost, with a TER of 0.10% against a group median of 0.09%. It has been listed since 2012, 14 years of track record.
On a €10,000 investment the TER costs 10 € a year. The cheapest of the group is Xtrackers MSCI USA UCITS ETF 1C at 0.03%, or 3 € on the same amount: a difference of 7 € every year, roughly 70 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 35.4% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in USD. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| NVIDIA Corporation | 7.1% |
| Apple Inc. | 6.6% |
| Microsoft Corporation | 4.1% |
| Amazon.com Inc | 3.6% |
| Alphabet Inc Class A | 3.2% |
| Broadcom Inc | 2.6% |
| Alphabet Inc Class C | 2.5% |
| Micron Technology Inc | 2.0% |
| Meta Platforms Inc. | 1.9% |
| Tesla Inc | 1.8% |
| Borsa Italiana | USAEUY | EUR |
| XETRA | UBU3 | EUR |
| Francoforte | UBU3 | EUR |
| London Stock Exchange | UC04 | GBX |
| London Stock Exchange | UC03 | USD |
| SIX Swiss Exchange | USAUSY | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.